SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-21-000037
Filing Date
2021-05-06
Accepted
2021-05-06 16:04:29
Documents
16
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20210506.htm   iXBRL 8-K 41977
2 EX-99.1 xlrn-20210506ex991.htm EX-99.1 102321
8 acceleronlogo_2021xemlsignb.gif GRAPHIC 5245
  Complete submission text file 0001280600-21-000037.txt   305448

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20210506.xsd EX-101.SCH 2457
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20210506_cal.xml EX-101.CAL 736
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20210506_def.xml EX-101.DEF 1673
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20210506_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20210506_pre.xml EX-101.PRE 12672
9 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20210506_htm.xml XML 10757
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 21897646
SIC: 2836 Biological Products, (No Diagnostic Substances)